jul 1, 2020 - Moderna COVID-19 vaccine candidate
Description:
In July 2020, the Moderna COVID-19 vaccine candidate, mRNA-1273, was shown in a Phase I trial to be immunogenic in a small number of volunteers aged 18–55 years
Added to timeline:
Date:
~ 4 years and 6 months ago